Immunocore Holdings PLC Sponsored ADR (IMCR) vs Rapport Therapeutics, Inc. (RAPP)
Immunocore Holdings PLC Sponsored ADR and Rapport Therapeutics, Inc. are both Biotechnology companies. Immunocore Holdings PLC Sponsored ADR and Rapport Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Rapport Therapeutics, Inc. has the higher net margin (0.00% vs −4.20%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Immunocore Holdings PLC Sponsored ADR leads on 6 and Rapport Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | IMCR | RAPP | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.90% | — | 65.16% |
| Operating margin | (5.24%) | 0.00% | 0.00% |
| Net margin | (4.20%) | 0.00% | 0.00% |
| Free cash flow margin | (9.55%) | 0.00% | 0.00% |
| Return on equity | (4.47%) | (39.96%) | (57.72%) |
| Return on assets | (1.64%) | (36.85%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack